Miroslav Šašinka, Katarína Furková
Fabry’s disease (angiokeratosis corporis diffusum) is an inborn error of glycosphingolipid metabolism with a deficiency of the lysosomal enzyme α-galactosidase A with a triglycosylceramid deposition in cellular lysosomes of many organs. A disease is transferred with X-linked heredity (GLA gen), ill are hemizygot men, women have less prominent symptoms. In men are various symptoms with attacks to many organs – Fabry’s cardiomyopathy, nephropathy, encefalopathy, dermopathy, pneumopathy, gastrointestinal tract disturbance and many others. The disease progression substantially shortens live longevity in men about 20 years and in women about 15 years. Now is effective enzymatic therapy but it’s have to early beginning. To this is needed early diagnosis and it is extraordinary serious because the symptoms are variable and nonspecific. Authors analyse etiopathogenesis, genetics, symptomatology, diagnostics, therapy and prognosis of Fabry’s disease.